Dr. Paul Streck, Head of R&D at PepGen, stated that all treatment-related adverse events in CONNECT1 have been mild and the safety profile of PGN-EDO51 appears favorable. The company remains ...

Ahead of next Tuesday's earnings release, Pfizer seems undervalued based on current price of $26.55 & valuation of $150bn. But is it madness to expect upside? Quite possibly it is. My DCF analysis ...

The Mission 300 Africa Energy Summit, in Dar es Salaam on January 27-28, 2025, will bring together leaders to accelerate energy access for 300 million people in Africa by 2030. Hosted by the United ...

Activist Starboard Value has decided not to pursue a proxy battle with Pfizer. Starboard built a $1 billion stake in Pfizer in October and reportedly planned to push for changes. Get two weeks of ...

Recently, Pfizer found itself in the agency's crosshairs thanks to one of its M&A plays. Now, Pfizer—which purchased neuroscience specialist Biohaven for $11.6 billion in 2022—is committing ...

Pfizer acquired Biohaven for $11.6bn in October 2022 based on a strong sales forecast for Nurtec ODT. Image credit: Shutterstock/Molly Woodward. Pfizer has agreed to pay $59.7m to resolve illegal ...

African Development Bank and World Bank in unprecedented collaboration to transform Africa’s Energy Access Strong emphasis on clean cooking solutions to avoid 600,000 deaths annually due to smoke ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so that physicians would prescribe a specific migraine drug to patients ...

DAR ES SALAAM, January 25, 2025 – African heads of state, business leaders, and development partners will converge tomorrow in Dar es Salaam, Tanzania, for the Mission 300 Africa Energy Summit where ...

Pfizer PFE-0.43%decrease; red down pointing triangle will pay $60 million to settle allegations that one of its subsidiaries incentivized healthcare providers to prescribe one of its drugs ...

NEW YORK, Jan 24 (Reuters) - Pfizer (PFE.N), opens new tab will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs by paying kickbacks ...

An oncology-focused Pfizer is poised to grow over the coming years. Abundant (and growing) earnings protect the dividend despite an abnormally high yield. The stock's valuation signals that the ...